Psiclone Limited
Company Profile
Psiclone Limited
13441162•Private Limited With Share Capital
Get Full Access
07/06/2021
4 years
3
5
21200
low risk
Company Overview
Registration, classification & business activity
Psiclone Limited (13441162) is a private limited with share capital incorporated on 07/06/2021 (4 years old) and registered in calne, SN110LP. The company operates under SIC code 21200 - manufacture of pharmaceutical preparations.
As former members of the gw pharmaceuticals executive team, where we learned to develop fda approved medicines from the cannabis plant, we have established psiclone to pursue the development of natural forms of psilocybin and related molecules using complex extracts obtained from fungal raw material...
Financial Overview
£23.4K
£251.2K
£-227.8K
£4.60M
£0
Key Metrics
5
Employees
3
Directors
1
Shareholders
Board of Directors
Filed Documents
Innovate Grants
This company received a grant of £296715.0 for An Innovative Mushroom Extract-Based Pharmaceutical Product To Help Opioid Use Disorder Patients Withdraw From Opioid Use. The project started on 01/06/2023 and ended on 30/11/2024.
Risk Assessment
low risk
International Score
Future Factor
emerging
Performance Rating